Skip to content

Multi-omics Study on Gut Microbiota in Critical Ill Patients After Cardiopulmonary Bypass

Clinical and Multi-omics Study on Gut Microbiota in Critical Ill Patients After Cardiovascular Surgery Combined Cardiopulmonary Bypass With or Without Sepsis(CPB-MUL-GM Study): a Prospective Study Protocol

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04032938
Acronym
CPB-MUL-GM
Enrollment
150
Registered
2019-07-25
Start date
2018-08-01
Completion date
2019-12-31
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Bypass, Sepsis

Keywords

Cardiopulmonary Bypass, Gastrointestinal Microbiome, Thoracic Surgery, Metagenomics, Metabolomics, sepsis

Brief summary

Using metagenomics as well as metabolomics, the variation of the gut microbiota and host metabolite profiles of patient after undergoing CPB were explored.

Detailed description

This protocol is designed as a prospective observational case-control study in patients who underwent cardiopulmonary bypass (CPB) due to cardiac surgery. 30 healthy persons were selected as control group. The case group included patients admitted to intensive care unit (ICU) after cardiac surgery and extracorporeal circulation which is performed by the Department of cardiac surgery of Peking Union Medical College Hospital. The patients enrolled should be divided into two groups according to their primary outcomes: one grouped fever and/or hemodynamic instability after cardiopulmonary bypass and the other grouped normothermia and normal hemodynamic during 48 hours after surgery(cause an infection manifested \>48 hours after admission was defined as hospital acquired. ). Sample collection was terminated when both groups received 30 cases. These 60 cases would regard as the case group. Additionally, all the CPB patients we observed will be divided into survivors and non-survivors based on the 28-day survival. Feces and blood samples will be obtained at certain time points(initial sampling at least one day before the surgery, repeat sampling within 24-48 hours after CPB). The fecal samples analysis will apply metagenomics and the feces and blood samples will be analyzed using untargeted metabolomics method. In this study, the stratification of gut microbial communities in patients underwent extracorporeal circulation were explored and analysed the variation of metabolite in patients's plasma and fecal samples. Predictive bio-markers and possible pathogenesis of fever and/or hemodynamic instability after CPB will be also provided by clinical outcomes analysis combined with multi-omics study.

Interventions

PROCEDUREextracorporeal circulation during cardiac surgery

We will observe the cardiopulmonary bypass status and time of patients undergoing cardiac surgery and extracorporeal circulation due to their medical needs.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients will be admitted to ICU between 18 and 85 years of age who will undergo extracorporeal circulation during cardiac surgery and provided written informed consent will be enrolled as candidates of case group. * Healthy volunteers will be enrolled as control group.

Exclusion criteria

* Patients had a fever before surgery, regardless of the etiological evidence of infection; * had anti-infective treatment before surgery; * had gastrointestinal surgery which left the digestive system dysfunctional; * had a history of CPB in 6 month; * reject or abandon ICU therapeutic intervention.

Design outcomes

Primary

MeasureTime frameDescription
SurgeryDuring sample collectioncardiovascular surgery with cardiopulmonary bypass VS. non-surgery non-surgery is defined as healthy people who don't need surgery.

Secondary

MeasureTime frameDescription
Anal temperaturewithin 24-48 hours after cardiopulmonary bypassFever VS. non-fever Definition: Fever: The axillary body temperature is over 38.3℃. Non-fever: The axillary body temperature is below or equal to 38.3℃.
Hemodynamicswithin 24-48 hours after cardiopulmonary bypassHemodynamic instability VS. normal hemodynamic Definition: Hemodynamic instability: Vasopressor therapy needed to elevate MAP (mean artarial pressure) ≥65 mmHg.
survivalwithin 28 days after CPBsurvivors vs. non-survivors survivor: Patients survive for 28 days or more after CPB. non-survivors: Patients survive less than 28 days after CPB.

Countries

China

Contacts

Primary ContactWenyan Ding, master
muse1yan@163.com18811152750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026